Monogram (MGRM) Insider Filing: Unis Reports 1.475M Shares, 35k-Option Grant
Rhea-AI Filing Summary
Douglas Unis, a director of Monogram Technologies Inc. (MGRM), received a stock option award and reports his beneficial ownership. The Form 4 discloses a grant of a stock option on 01/08/2025 to purchase 35,000 shares of common stock with an exercise price of $2.50. The option becomes exercisable on 01/08/2032 and expires on 01/08/2035. After this transaction, the filing reports 1,475,000 shares beneficially owned by Mr. Unis held directly. The form includes a note that the company uses the Black-Scholes model to value stock awards.
Positive
- Grant of 35,000 stock options at a stated $2.50 exercise price, indicating equity-based alignment between the director and shareholders
- High reported direct beneficial ownership of 1,475,000 shares, showing substantial insider ownership by the reporting person
Negative
- None.
Insights
TL;DR Routine director option grant; increases director alignment with shareholders but is not a market-moving disclosure by itself.
The Form 4 shows a non-derivative grant in the form of a stock option exercisable in 2032 and expiring in 2035 for 35,000 shares at $2.50. This is a standard equity-based compensation mechanism for directors to align incentives with long-term shareholder value. The significant reported direct beneficial ownership of 1,475,000 shares suggests material insider ownership by the reporting person, which can be governance-positive in terms of alignment. The disclosure is procedural and does not disclose any transfers, sales, or unusual terms beyond exercise date and expiration.
TL;DR A typical option award disclosed under Section 16; details confirm exercise price and long vest/exercise timeline.
The document lists a stock option issued 01/08/2025 for 35,000 underlying shares at a $2.50 strike, exercisable beginning 01/08/2032 with a 01/08/2035 expiration. The filing includes the company note that Black-Scholes is used to value awards. No cash sales, dispositions, or derivative exercises are reported. From a compensation perspective, the long delay to exercisability indicates a multi-year retention/long-term alignment design. No other compensation metrics or grant-date fair value are provided in this Form 4.
FAQ
What did Douglas Unis report on the Form 4 for MGRM?
How many shares does Douglas Unis beneficially own after the reported transaction?
When was the transaction dated and when was the Form 4 signed?
What valuation method does the company use for stock awards?
What are the exercise and expiration dates for the option awarded?